{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:42:29Z","timestamp":1785825749733,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005405","name":"American Surgical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["K12TR004908"],"award-info":[{"award-number":["K12TR004908"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["T32 CA009599"],"award-info":[{"award-number":["T32 CA009599"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA221707"],"award-info":[{"award-number":["P50CA221707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["surgoncinsight.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Insight"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.soi.2025.100150","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T02:41:30Z","timestamp":1747363290000},"page":"100150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burden"],"prefix":"10.1016","volume":"2","author":[{"given":"Paula","family":"Marincola Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee","family":"Seldomridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ju","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Scally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith F.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Helmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soi.2025.100150_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.soi.2025.100150_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-0038-1642052","article-title":"The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal tumors and colorectal adenocarcinomas","volume":"31","author":"Kuncewitch","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.soi.2025.100150_bib3","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1245\/s10434-021-10856-8","article-title":"The landmark series: appendiceal primary peritoneal surface malignancy","volume":"29","author":"Gangi","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.soi.2025.100150_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.soi.2025.100150_bib5","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-021-10049-3","article-title":"The landmark series: surgical treatment of colorectal cancer peritoneal metastases","volume":"28","author":"Bijelic","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soi.2025.100150_bib6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.soi.2025.100150_bib7","first-page":"29","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Adv Surg Tech"},{"issue":"8","key":"10.1016\/j.soi.2025.100150_bib8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamaoncol.2021.0580","article-title":"Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review","volume":"7","author":"van Stein","year":"2021","journal-title":"JAMA Oncol"},{"issue":"23","key":"10.1016\/j.soi.2025.100150_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235824","article-title":"Complications and mortality rate of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: italian peritoneal surface malignancies oncoteam results analysis","volume":"14","author":"Carboni","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.soi.2025.100150_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.soi.2025.100150_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jso.25967","article-title":"Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer","volume":"122","author":"Chen","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.soi.2025.100150_bib12","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1245\/s10434-021-10856-8","article-title":"The landmark series: appendiceal primary peritoneal surface malignancy","volume":"29","author":"Gangi","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soi.2025.100150_bib13","article-title":"The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery","volume":"156","author":"Kusamara","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.soi.2025.100150_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","article-title":"Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy","volume":"92","author":"Elias","year":"2001","journal-title":"Cancer"},{"issue":"98","key":"10.1016\/j.soi.2025.100150_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"15","author":"Gomez Portilla","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.soi.2025.100150_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"6","key":"10.1016\/j.soi.2025.100150_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J Am Coll Surg"},{"issue":"10","key":"10.1016\/j.soi.2025.100150_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ejso.2006.06.007","article-title":"Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival","volume":"32","author":"Yan","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.soi.2025.100150_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejso.2004.09.021","article-title":"Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy","volume":"31","author":"Kecmanovic","year":"2005","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.soi.2025.100150_bib20","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","article-title":"Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study","volume":"22","author":"Goere","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soi.2025.100150_bib21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.soi.2025.100150_bib22","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soi.2025.100150_bib23","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-021-10049-3","article-title":"The landmark series: surgical treatment of colorectal cancer peritoneal metastases","volume":"28","author":"Bijelic","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soi.2025.100150_bib24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","article-title":"Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1000 patients","volume":"218","author":"Levine","year":"2014","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.soi.2025.100150_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archsurg.138.1.26","article-title":"Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis","volume":"138","author":"Shen","year":"2003","journal-title":"Arch Surg"},{"key":"10.1016\/j.soi.2025.100150_bib26","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s002800051093","article-title":"Successful management of microscopic residual disease in large bowel cancer","volume":"43","author":"Sugarbaker","year":"1999","journal-title":"Cancer Chemother Pharm"},{"issue":"9","key":"10.1016\/j.soi.2025.100150_bib27","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1245\/s10434-017-5938-8","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for moderately and poorly differentiated appendiceal adenocarcinoma: survival outcomes and patient selection","volume":"24","author":"Grotz","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soi.2025.100150_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4251\/wjgo.v9.i9.354","article-title":"Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade","volume":"9","author":"Grotz","year":"2017","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.soi.2025.100150_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamasurg.2023.0112","article-title":"Development and validation of nomograms to predict survival in patients undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin","volume":"158","author":"Chandrakumaran","year":"2023","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.soi.2025.100150_bib30","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1245\/s10434-022-11894-6","article-title":"Systemic chemotherapy for high-grade mucinous appendiceal cancer with peritoneal spread after unsuccessful CRS\/HIPEC","volume":"29","author":"Baron","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soi.2025.100150_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jso.26520","article-title":"Peritoneal cytology as an indicator of peritoneal metastases in colorectal cancer","volume":"124","author":"Sugarbaker","year":"2021","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.soi.2025.100150_bib32","first-page":"206","article-title":"Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction","volume":"32","author":"Velasquez","year":"2024","journal-title":"Support Care Cancer"},{"issue":"16","key":"10.1016\/j.soi.2025.100150_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.25116","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis","volume":"116","author":"Franko","year":"2010","journal-title":"Cancer"}],"container-title":["Surgical Oncology Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950247025000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950247025000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T02:26:03Z","timestamp":1762655163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950247025000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2950247025000295"],"URL":"https:\/\/doi.org\/10.1016\/j.soi.2025.100150","relation":{},"ISSN":["2950-2470"],"issn-type":[{"value":"2950-2470","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burden","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soi.2025.100150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Society of Surgical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100150"}}